Nasdaq rules provide a 180-calendar day cure period from the date of a deficiency notice based on the minimum bid price, during which the minimum bid price of a company's stock must be $1 or more for ten consecutive business days to avoid delisting. See Nasdaq Rule 5810(c)(3)(A). If a company is listed on the Nasdaq Capital Market, the company is eligible for a second 180-calendar day cure period if it meets certain requirements. See Nasdaq Rule 5810(c)(3)(A)(ii). If a company is listed on the Nasdaq Global Select Market or Nasdaq Global Market, the company may be eligible for a second 180-calendar day cure period if it transfers to the Nasdaq Capital Market and meets certain requirements. See Nasdaq Rule 5810(c)(3)(A)(i).